trial

Treating Thought Problems in Patients With Schizophrenia

NCTId NCT00051740
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 120 (estimated)
Sponsored by The University of Texas Health Science Center at San Antonio
Primary completion 2008-10
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
120 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2002-02
Primary completion
2008-10
Eligibility
ALL · 18 Years · 60 Years

Interventions & indications

Drugs
Cognitive Adaptation Therapy (CAT)Minimal Environmental Supports (MES)

Sponsors

The University of Texas Health Science Center at San AntonioLead Sponsor

Investigators

1
Dawn' I Velligan, Ph.D.Principal Investigator

Sites

1 total
San Antonio, United States

Facts & assertions

4 sourced
Enrollment
120
Phase
NA
Primary Completion Date
2008-10
Status
COMPLETED
relationships
The graph out of here
drug
Cognitive Adaptation Therapy (CAT)
drug
Minimal Environmental Supports (MES)
drug
lead_sponsor
The University of Texas Health Science Center at San Antonio
company
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
Dawn' I Velligan, Ph.D.
person